Legend Biotech Surges Amid Takeover Speculation

Seeking AlphaJan 11 01:47

Have Insiders Sold Ligand Pharmaceuticals Shares Recently?

Simply Wall StJan 1 20:24

Earnings Grew Faster Than the Notable 60% Return Delivered to Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Over the Last Year

Simply Wall StDec 24, 2024 02:26

Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $135

Futu NewsDec 23, 2024 20:33 · Ratings

Ligand Pharmaceuticals Is Maintained at Overweight by Barclays

Dow JonesDec 16, 2024 22:52 · Ratings

Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $160

Futu NewsDec 16, 2024 19:31 · Ratings